Sani H Kizilbash

12PUBLICATIONS
190CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMining, energy and natural resources lawMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 08, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

|Dec 19, 2025
Clinical Implications of Aberrant Retinoblastoma Signaling in Patients With Grade 4 IDH-Mutant Astrocytoma: A Retrospective Cohort Study.

Muhammad Asad Maqbool, Robert B Jenkins, Cristiane M Ida

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Sep 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

James J Harding, Do-Youn Oh, Teresa Macarulla Mercade

|Apr 09, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.

Seshiru Nakazawa, Federica Pecci, Igor Odintsov

|Feb 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas.

Mohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson

Pageof 2

Frequent Collaborators

4 joint publications

Cecile Riviere-Cazaux

4 joint publications

Terry C Burns

3 joint publications

Jann N Sarkaria

2 joint publications

David M Routman